/

Empresas

Pa

No verificado

Papillon Therapeutics Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaHigiene alimentariaIndustriaSalud

4 Comunicados de prensa

Ver todos los comunicados de prensa

21/10/2024

Industria

Biotecnología

Farmacéutica

Salud

Papillon Therapeutics Receives Rare Pediatric Disease Designation from the U.S. Food and Drug Administration for PPL-002 for the Treatment of Danon Disease

Fuente

Papillon Therapeutics Inc.

Editor

1.00

0

15/10/2024

Industria

Higiene alimentaria

VIH, SIDA y enfermedades autoinmunes

Salud

Biotecnología

Papillon Therapeutics Receives Rare Pediatric Disease Designation from the U.S. Food and Drug Administration for PPL-001 for the Treatment of Friedreich's Ataxia

Fuente

Papillon Therapeutics Inc.

Editor

1.00

0

01/10/2024

Industria

Salud

Higiene alimentaria

Biología

Biotecnología

Medicina - Varios

Farmacéutica

Papillon Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for PPL-002 for the Treatment of Danon Disease

Fuente

Papillon Therapeutics Inc.

Editor

1.00

0

17/09/2024

Higiene alimentaria

Salud

Biotecnología

Medicina - Varios

Farmacéutica

Papillon Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for PPL-001 for the Treatment of Friedreich's Ataxia

Fuente

Papillon Therapeutics Inc.

Editor

1.00

0

Seguidores

0

Compatibilidad

0